Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ

Canada

FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS/Arnd Wiegmann/File Photo

(Reuters) – Swiss drugmaker Novartis AG (NOVN.S) is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co (MDCO.O) for about $7 billion, the Wall Street Journal reported on Saturday.

The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the matter.

Neither Novartis nor The Medicines Co were immediately available for comment on Saturday.

Reporting by Kanishka Singh in Bengaluru; editing by Jonathan Oatis

Products You May Like

Articles You May Like

Prepare to study in Canada
Study permit: Who can apply
Finding A School For Your Children As A New Immigrant To Canada: A Comprehensive Guide
Canada Immigrants Increasingly Likely To Land Jobs And Get Better Pay
Canada Issues 1,470 Invitations to Apply (ITAs) Under All-Program Draw
Canada Issues 2,500 Invitations to Apply (ITAs) for French Language Speakers
Quebec Expression Of Interest Draw: Province Issues 1,034 Canada Immigration Invitations

Leave a Reply

Your email address will not be published. Required fields are marked *